These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38597504)

  • 1. Breaking barriers: How modified citrus pectin inhibits galectin-8.
    Shuai M; Li Y; Guan F; Fu G; Sun C; Ren Q; Wang L; Zhang T
    Food Funct; 2024 May; 15(9):4887-4893. PubMed ID: 38597504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification, chemical analysis and inhibitory effects on galectin-3 of enzymatic pH-modified citrus pectin.
    Zhang T; Sun G; Shuai M; Ye J; Huang J; Yao X; Sun C; Min X
    Food Chem X; 2021 Dec; 12():100169. PubMed ID: 34877529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship of Citrus segment membrane RG-I pectin against Galectin-3: The galactan is not the only important factor.
    Wu D; Zheng J; Hu W; Zheng X; He Q; Linhardt RJ; Ye X; Chen S
    Carbohydr Polym; 2020 Oct; 245():116526. PubMed ID: 32718630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified citrus pectin reduces galectin-3 expression and disease severity in experimental acute kidney injury.
    Kolatsi-Joannou M; Price KL; Winyard PJ; Long DA
    PLoS One; 2011 Apr; 6(4):e18683. PubMed ID: 21494626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the neutral polysaccharide fraction of MCP and its inhibitory activity on galectin-3.
    Gao X; Zhi Y; Zhang T; Xue H; Wang X; Foday AD; Tai G; Zhou Y
    Glycoconj J; 2012 May; 29(4):159-65. PubMed ID: 22562786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin.
    Nangia-Makker P; Hogan V; Honjo Y; Baccarini S; Tait L; Bresalier R; Raz A
    J Natl Cancer Inst; 2002 Dec; 94(24):1854-62. PubMed ID: 12488479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified citrus pectin inhibited bladder tumor growth through downregulation of galectin-3.
    Fang T; Liu DD; Ning HM; Dan Liu ; Sun JY; Huang XJ; Dong Y; Geng MY; Yun SF; Yan J; Huang RM
    Acta Pharmacol Sin; 2018 Dec; 39(12):1885-1893. PubMed ID: 29769742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleiotropic Effects of Modified Citrus Pectin.
    Eliaz I; Raz A
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31683865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of modified citrus pectin on galectin-3 inhibition in cisplatin-induced cardiac and renal toxicity.
    Santos DD; Belote NM; Sasso GRS; Correia-Silva RD; Franco PC; da Silva Neto AF; Borges FT; Oyama LM; Gil CD
    Toxicology; 2024 May; 504():153786. PubMed ID: 38522819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified citrus pectin stops progression of liver fibrosis by inhibiting galectin-3 and inducing apoptosis of stellate cells.
    Abu-Elsaad NM; Elkashef WF
    Can J Physiol Pharmacol; 2016 May; 94(5):554-62. PubMed ID: 27010252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of galectin-3 in liver metastasis of colon cancer and the inhibitory effect of modified citrus pectin].
    Huang ZL; Liu HY
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1358-61. PubMed ID: 18753060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pectin: Health-promoting properties as a natural galectin-3 inhibitor.
    An L; Chang G; Zhang L; Wang P; Gao W; Li X
    Glycoconj J; 2024 Apr; 41(2):93-118. PubMed ID: 38630380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified citrus pectin inhibits galectin-3 function to reduce atherosclerotic lesions in apoE-deficient mice.
    Lu Y; Zhang M; Zhao P; Jia M; Liu B; Jia Q; Guo J; Dou L; Li J
    Mol Med Rep; 2017 Jul; 16(1):647-653. PubMed ID: 28560429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low or No Inhibitory Potency of the Canonical Galectin Carbohydrate-binding Site by Pectins and Galactomannans.
    Stegmayr J; Lepur A; Kahl-Knutson B; Aguilar-Moncayo M; Klyosov AA; Field RA; Oredsson S; Nilsson UJ; Leffler H
    J Biol Chem; 2016 Jun; 291(25):13318-34. PubMed ID: 27129206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified citrus pectin ameliorates myocardial fibrosis and inflammation via suppressing galectin-3 and TLR4/MyD88/NF-κB signaling pathway.
    Xu GR; Zhang C; Yang HX; Sun JH; Zhang Y; Yao TT; Li Y; Ruan L; An R; Li AY
    Biomed Pharmacother; 2020 Jun; 126():110071. PubMed ID: 32172066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified Citrus Pectin Prevents Blood-Brain Barrier Disruption in Mouse Subarachnoid Hemorrhage by Inhibiting Galectin-3.
    Nishikawa H; Liu L; Nakano F; Kawakita F; Kanamaru H; Nakatsuka Y; Okada T; Suzuki H
    Stroke; 2018 Nov; 49(11):2743-2751. PubMed ID: 30355205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified Citrus Pectin as a Potential Sensitizer for Radiotherapy in Prostate Cancer.
    Conti S; Vexler A; Hagoel L; Kalich-Philosoph L; Corn BW; Honig N; Shtraus N; Meir Y; Ron I; Eliaz I; Lev-Ari S
    Integr Cancer Ther; 2018 Dec; 17(4):1225-1234. PubMed ID: 30043669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pectasol-C Modified Citrus Pectin targets Galectin-3-induced STAT3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroids.
    Hossein G; Halvaei S; Heidarian Y; Dehghani-Ghobadi Z; Hassani M; Hosseini H; Naderi N; Sheikh Hassani S
    Cancer Med; 2019 Aug; 8(9):4315-4329. PubMed ID: 31197964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plant-derived saccharides and their inhibitory potential on metastasis associated cellular processes of pancreatic ductal adenocarcinoma cells.
    Schöll-Naderer M; Helm O; Spencker J; Pfeifer L; Rätsch T; Sebens S; Classen B
    Carbohydr Res; 2020 Apr; 490():107903. PubMed ID: 32171073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified citrus pectin anti-metastatic properties: one bullet, multiple targets.
    Glinsky VV; Raz A
    Carbohydr Res; 2009 Sep; 344(14):1788-91. PubMed ID: 19061992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.